Chemokine Therapeutics Corp. discovers and develops peptide analogs of chemokines for cancer treatment, and immune system recovery.

Chemokine Therapeutics Corp. is a publicly-held biotechnology company with expertise in chemokine-based drugs.



 2008 AACR Annual Meeting Presentations

OTCBB
CHKT /$0.16
TSX
CTI /$0.19
Charts indicate 1 mo period

Today's Market Information


Copyright © 2006 Chemokine Therapeutics Corporation. All rights reserved.